Business
SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER
SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER C...
About this update from Seegnal Inc.
[{"type":"text","content":"\n\n\nSEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\n/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/\nCALGARY, AB, Nov. 17, 2025 /CNW/ - Seegnal Inc. (TSXV: SEGN) (\"Seegnal\" or the \"Corporation\"), a global leader in SaaS-based clinical decision support solutions for detecting and resolving drug-related problems, is pleased to announce the appointment of Elad Bibi-Aviv, Esq. as Chief Executive Officer of Seegnal Inc. effective December 16, 2025.\nBibi-Aviv brings extensive leadership experience across the AI, fintech, biotech and health-tech industries, with a proven track record in scaling revenue operations and driving strategic growth. A two-time exit entrepreneur, he has built and led high-performing teams in both startup and established ventures.\nBetween 2021 and 2022, Bibi-Aviv founded and served as CEO of Covary, an Israeli insurtech company, where he led the company to more than 10,000 customers. Following Covary's success in the U.S. market, he played a key role in its acquisition by a U.S. insurance carrier, just two years after its founding.\nAfter the acquisition, Bibi-Aviv joined NeuroKaire, an Israeli AI-driven health-technology provider that leverages artificial intelligence and stem-cell technology to match patients with effective psychiatric medications and eliminate the trial-and-error process in prescribing. At NeuroKaire, he led the company's operations, regulations and sales to U.S. healthcare providers and HMOs.\nBibi-Aviv succeeds Mr. Eyal Schneid, who will continue to make valuable contributions to Seegnal in his new role as General Manager of Seegnal E-Health Ltd., the operating subsidiary of Seegnal in Israel.\nMr. Nir Dor, Chairman of Seegnal, commented: \"We are delighted to welcome Elad Bibi-Aviv to Seegnal's leadership team. His proven experience in building AI companies and successfully selling to healthcare providers in the U.S. positions him perfect...